drugset / Trial / NCT05113901

Medrol Dosepak Taper for Delayed Post-op Recovery After TKA

NCT05113901 ↗

Phase 4 Terminated 4 enrolled Rush University Medical Center
RandomizedParallel-groupTriple-blindPrevention

Summary

To evaluate the efficacy of a methylprednisolone taper on patients with decreased range of motion (ROM) or delayed recovery in the acute postoperative period following total knee arthroplasty (TKA). Patients with decreased ROM or delayed recovery six weeks to three months post-TKA will improve ROM and patient-reported outcomes at two weeks post-treatment initiation of methylprednisolone taper, as compared to similar patients who receive a placebo taper.

Timeline

Start
2022-03-03
Primary completion
2022-07-01
Completion
2022-07-25

Outcome

Outcome not reported

Stopped: “Extremely low participation, decided to focus on similar study instead”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 4 mg Oral

Indications

No indication recorded.